(1, 14) Cytokeratin
, however, is not a useful marker because it can be expressed in both PMDM and pseudotumoral deciduosis.
5/6 and p63 are the recently added markers which also help in differentiating PMA from metastatic mucinous adenocarcinoma, as proposed by various studies.
immunoreactivity in Ewing sarcoma/primitive neuroectodermal tumour.
expression level in the VEGF-BMSC group was slightly higher than that of the BMSC group and sham operation group without a significant difference and was significantly higher compared with the control group.
Spearman's correlation coefficients obtained for the correlations between adenosine deaminase and cytokeratin
19 fragments in pleural fluids were significantly positive for adenocarcinomas and significantly negative for a heterogeneous group of other diseases, including Dressler syndrome, melanocarcinoma, chylothorax, and leukemia, as shown in Table 3.
(d) Both the seminoma (top) and Leydig cell tumor (bottom) are negative for cytokeratin
Immunohistochemically, our tumor was positive for vimentin, CD34, and renin, along with CD10, MUC1, smooth muscle actin, and caldesmon, while it was negative for cytokeratin
(AE1/AE3), EMA, CD99, HMB45, and STAT6.
Immunohistochemistry showed cytokeratin
5/6 (+) (c, 10x), P63 (+) (d, 10x), cytokeratin
7 (-), TTF-1 (-) and Ki67 (50%).
The main ones include cytokeratin
19, Galectin 3 and HBME 1.
Immunohistochemically, cells stain positive for antibodies to cytokeratin
8 (CAM 5.2), actin, vimentin and cytokeratin
14 and negative for cytokeratin
18 and 19.
Along with cytokeratin
8, CK-18 is the only cytokeratin
found in the hepatocytes .
Immunohistochemical (IHC) stains showed cytokeratin
7 positive, cytokeratin
20 positive (Figure 5), Caudal Type Homeobox 2 (CDX2) positive (Figure 6), GATA3 negative in neoplastic cells (Figure 7), and Uroplakin negative in neoplastic cells (Figure 8).